Recursion Pharmaceuticals, Inc.
RXRX
$6.35
$0.416.90%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 51.79% | 10.41% | 16.87% | -37.37% | -28.79% |
| Total Receivables | 1,489.08% | -28.73% | -17.21% | 26.35% | 12.39% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 62.73% | 120.95% | 105.93% | 164.08% | 153.53% |
| Total Current Assets | 63.02% | 15.50% | 21.20% | -30.18% | -23.11% |
|
|
|||||
| Total Current Assets | 63.02% | 15.50% | 21.20% | -30.18% | -23.11% |
| Net Property, Plant & Equipment | 94.06% | 32.32% | 25.36% | -2.32% | -1.05% |
| Long-term Investments | 185.99% | -1.32% | -13.98% | 6,398.88% | 6,398.88% |
| Goodwill | 185.99% | -1.32% | -13.98% | 6,398.88% | 6,398.88% |
| Total Other Intangibles | 821.59% | -13.60% | -10.63% | 2,409.56% | 2,690.43% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 137.85% | -10.21% | -10.36% | -13.98% | -13.01% |
| Total Assets | 121.60% | 15.17% | 16.37% | -11.08% | -6.79% |
|
|
|||||
| Total Accounts Payable | 446.75% | -47.01% | 80.35% | 20.44% | -13.80% |
| Total Accrued Expenses | 92.23% | 120.24% | -4.23% | -0.62% | 37.90% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 260.89% | 171.93% | 183.56% | 19.92% | 1.79% |
| Total Finance Division Other Current Liabilities | 53.42% | -22.29% | -53.32% | -34.55% | -30.41% |
| Total Other Current Liabilities | 53.42% | -22.29% | -53.32% | -34.55% | -30.41% |
| Total Current Liabilities | 101.21% | 15.69% | -24.46% | -19.78% | -7.08% |
|
|
|||||
| Total Current Liabilities | 101.21% | 15.69% | -24.46% | -19.78% | -7.08% |
| Long-Term Debt | -37.87% | -9.86% | -- | -9.16% | 105.41% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 97.14% | 65.14% | 59.56% | -6.38% | -2.26% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 166.41% | -64.59% | -12.52% | -33.58% | -25.17% |
| Total Liabilities | 117.50% | 4.71% | -3.20% | -20.54% | -11.70% |
|
|
|||||
| Common Stock & APIC | 72.86% | 35.38% | 39.22% | 28.64% | 27.16% |
| Retained Earnings | -47.92% | -43.19% | -47.97% | -50.24% | -51.30% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 123.28% | 19.77% | 24.63% | -6.75% | -4.60% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 123.28% | 19.77% | 24.63% | -6.75% | -4.60% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 123.28% | 19.77% | 24.63% | -6.75% | -4.60% |
|
|
|||||
